Public Private Partnerships Strenghtening Innovation and Research in Europe CARRYING the TORCH for MEDICAL INNOVATION
Total Page:16
File Type:pdf, Size:1020Kb
December 2017 - n°49 Public Private PartnershiPs Strenghtening innovation and reSearch in europe CARRYING THE TORCH FOR MEDICAL INNOVATION Find out more about IMI Visit our website: www.imi.europa.eu Follow us on Twitter: @IMI_JU #carrythetorch EFP29312 IMI European Files 210x297.indd 1 17/11/2017 10:26 JTI S S EC T ORS : N EW A MB iti O N S – N EW S C A LE | T HE E UROPEAN F ILES | 3 EDITORIAL PUBLIC PRIVATE PARTNERSHIPS STRENGHTENING INNOVATION AND RESEARCH IN EUROPE he European Union is halfway through at a continental scale. This is because the and Transport, Clean Energy and--perhaps the Horizon 2020 (H2020) framework subjects of these ETPs and their objectives a testament to its importance in European T for innovation and the journey so far are both too large in impact and necessarily society-- the two separate initiatives on Infor- is ripe for evaluation. H2020 is unique as a unachievable through national initiatives. mation and Communications Technologies Framework Program for research and devel- Having identified key research themes such as lend themselves well to the management of opment due to its sheer scale in budget and Health or Transport research, the JTIs enable research programs in an “integrated manner”. duration. With lifespan of 7 years and an initial large-scale programs to extend the reach of As the evaluation of H2020 thus far reveals total budget of EUR 77 billion, it encourages H2020’s impact potential. For example, the certain gaps in its implementation, it is members of public research institutions, Innovative Medicines Initiative was created possible the European Union already pos- private organizations, and interested parties to tackle “bottlenecks currently limiting sesses working solutions within the breadth of at large to come together over strategic tech- the efficiency, effectiveness and quality of financing or organizing programs such as JTIs nological sectors. It does this by boasting one the drug development activities needed to and the accompanying Joint Undertakings. of the most sophisticated and comprehensive bring innovative medicines to the market”. This issue of the European Files… funding portfolio enabling a variety of actors Europe’s ability to unite all stakeholders to find funding for their projects, big or small. involved in the financing, development, LAURENT ULMANN TWith the noble ambition of organizing research approval, and marketing of new medicines that will contribute to “building a society and is crucial to maintaining a competitive phar- economy based on knowledge and innovation maceutical industry to properly address across the Union”, H2020 stands out as itself a the Union and its citizens’ needs. Programs pioneering program for innovation. funded under JTIs each benefit from unique approaches to research and development, It is clear that part of its strength as an including measures of “open innovation” institutional tool for innovation stems from enabling cross-company collaboration and its versatile financing packages to projects asset sharing. of all sizes. H2020 includes a set of strategic research sectors and promises to review each In fact, H2020 wholly deserves the attention bid based on potential impact. Although the of the interim evaluation to review and revise effectiveness of this approach cannot be fully its capacity to maintain a high level of efficacy evaluated at this time, several ambitious ini- in delivering innovation to Europe’s citizens. tiatives have been launched, refinanced, and Doubly important is the public’s awareness improved to meet a standard of excellence. and perception of these innovation initiatives. One of the most exciting approaches to Whereas some projects may be so focused research that has experienced new life under as to invite very specialized interest groups, H2020 is the Joint Technology Initiative (JTIs). the JTIs offer an innovation scope relevant to Although some research sectors may benefit several Member States and its citizens. Key from a highly focused scope, several Strategic technological advances must have the capacity Research Agendas require coordination and to open and drive new markets. The break- leadership in European Technology Platforms throughs required in sectors as large as Health Management: The European Files / Les Dossiers Européens - 19 rue Lincoln, 1180 Brussels www.europeanfiles.eu - ISSN 1636-6085 - email: [email protected] - Publication Director and Editor-in-Chief: Laurent ULMANN - Intern: Raphaël Benros Layout & printing: VAN RUYS PRINTING Copyright: Shutterstock 4 | T HE E UROPEAN F ILES | JTI S S EC T ORS : N EW A MB iti O N S – N EW S C A LE TABLE OF CONTENTS PPP’s for a long-term vision for The Innovative Medicines Initiative: taking open competitiveness in Europe 6 innovation to the next level 14 Jyrki Katainen, Vice-President and Commissioner Jobs, Pierre Meulien, Executive Director, Growth, Investment and Competitiveness, European Innovative Medicines Initiative Commission The Innovative Medicines Initiative: Horizon 2020 Review: Towards a more coherent Carrying the torch of medical innovation 16 R&I funding landscape 7 Magda Chlebus, Executive Director, Science Policy & Mailis Reps, Estonian Minister of Education and Research Regulatory Affairs, European Federation of Pharmaceutical Industries and Associations (EFPIA) Streamlining European Research Initiatives 8 Frédérique Vidal, French Minister of Higher Education, Value of Private Public Partnerships to Research, and Innovation address Infectious Disease Risks and needs for epidemic prevention 18 Pushing a long-term vision for PPPs 9 Jean Lang, MD, PhD, Associate Vice President R&D, Global Health, Partnerships & Funding, Sanofi Pasteur Jarosław Gowin, Polish Minister of Science and Higher Education Corinne Bardone, Pharm D, Head of Global Vaccines Public Affairs for Polio, Pertussis and Hib Vaccines, Sanofi Pasteur Preparing for FP9: Reinforcing JTIs and their potential 10 Jörg Leichtfried, Federal Minister for Transport, Innovation and Technology of the Republic of Austria Energy sector PPP initiatives in the context of the European Energy Regional Impact of Joint Technology Initiates and Union - A powerful element for a sustainable energy Public-Private Partnerships for European system 20 Competitiveness and Innovation 11 Paul Rübig, MEP (EPP Group), Member of the ITRE Markku Markkula, The First Vice-President of the European Committee Committee of the Regions (CoR) and City councillor of Espoo Joint Undertakings: an efficient tool toward the energy transition 21 JTIs Sectors: New Ambitions – New Scale Dominique Ristori, Director-General, DG Energy, European Commission Health sector Advantages of a JU for a Clean Energy future 22 IMI contributes to efforts to accelerate access to Bart Biebuyck, Executive Director of FCH2 affordable, innovative medicine 12 Miroslav Poche, Miroslav Poche, MEP (S&D Group), Bio-Economy sector Member of the ITRE Committee To boost and facilitate the process of dispersion of PPPs: The Patients’ View 13 new technologies the role of SME’s is crucial through Nicola Bedlington, EPF Secretary General the PPP 24 Andor DELI, MEP (EPP Group), Member of the TRAN Committee JTI S S EC T ORS : N EW A MB iti O N S – N EW S C A LE | T HE E UROPEAN F ILES | 5 The necessity to sustainable bio-based economy Transport in the EU 25 Franc Bogovič, MEP (EPP Group), Member of the REGI The future of Joint Technology Initiatives in Committee the field of digital transport 36 Henrik Hololei, Director-General for Mobility and Transport, Strengthening European bio-based industries in a European Commission. competitive global market 26 Philippe Mengal, Executive Director of Bio-based Industries Aviation Strategy for Europe, the importance of JTIs 37 Joint Undertaking (BBI JU) Pavel Telička, MEP, Vice-President of the European Parliament Committee for Transport and Tourism Group of Taking stock of Europe’s bio-based industries: the Alliance of Liberals and Democrats for Europe new sectors, new value chains, new investments 28 Dirk Carrez, Executive Director, Bio-based Industries Upgrading Europe’s skies, digitally 38 Consortium Florian Guillermet, Executive Director, SESAR Joint Undertaking Investment framework to build a competitive, dynamic and sustainable bioeconomy in Europe 30 Clean Sky: Innovative results for a more Miapetra Kumpula-Natri, MEP (S&D Group), Chair of the competitive Europe 40 Bioeconomy Working Group, EP Intergroup “Climate Change, Tiit Jürimäe, Interim Executive Director, Clean Sky 2 Joint Biodiversity, and Sustainable Development”, Member of the Undertaking ITRE Committee Shift2Rail: no train, no gain 42 Dominique Riquet, MEP (ALDE Group), Vice-Chair of the Digital sector TRAN Committee Public-Private-Partnerships in Horizon 2020 and beyond 31 JTIs in Rail: Tackling a European transport Roberto Viola, Director General DG CNECT, challenge with a new comprehensive approach 44 Executive Director of Shift2Rail European Commission Carlo Borghini, ECSEL Joint Undertaking: shaping digital innovation 32 Energy efficiency in the field of transport, Bert de Colvenaer, Executive Director of the ECSEL JU a societal requirement 46 Gesine Meissner, MEP (ALDE Group), Member of the TRAN Committee Joint Technology Initiatives and Joint Undertakings: speeding up Europe 34 Lambert van Nistelrooij, MEP (EPP Group), Member of REGI Committee Stimulating the innovation through of the PPP’s 35 Marian-Jean Marinescu, MEP (EPP Group), Member of the TRAN Committee 6 | T HE E UROPEAN F ILES | S T RE N GH T E nin G I nn OV